Edges in Network
Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
Node | SLC2A1 |
Upstream (Parents) |
---|
(<<) GLB1L2 → SLC2A1 |
(<<) PKM2 → SLC2A1 |
(<<) ALDOA → SLC2A1 |
(<<) EFNB2 → SLC2A1 |
Downstream (Children) |
---|
SLC2A1 → LAMA5 (>>) |
SLC2A1 → POU4F1 (>>) |
SLC2A1 → MAGEA2B///MAGEA6///MAGEA3///MAGEA2 (>>) |
SLC2A1 → WNT11 (>>) |
SLC2A1 → PMEPA1 (>>) |
SLC2A1 → EPHA2 (>>) |
SLC2A1 → EFNB2 (>>) |
SLC2A1 → S100A3 (>>) |
SLC2A1 → FLT3 (>>) |
SLC2A1 → FAM184A (>>) |